Skip to content

Clinical trials

Muscular Dystrophy, Duchenne trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Country / region: Netherlands Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20102
20111
20122
20133
20141
20162
20173
20184
20191
20203
20214
20221
20231
20243
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated11
Recruiting5
Active, not recruiting3
Enrolling by invitation2
Unknown status1
Not yet recruiting1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical9
Italfarmaco5
GlaxoSmithKline3
Santhera Pharmaceuticals3
Edgewise Therapeutics, Inc.2
Entrada Therapeutics, Inc.2
Great Ormond Street Hospital for Children NHS Foundation Trust2
Kyntra Bio2
NS Pharma, Inc.2
Sarepta Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne39
Muscular Dystrophies7
Muscular Diseases3
Genetic Diseases, Inborn2
Muscular Disorders, Atrophic2
Musculoskeletal Diseases2
Nervous System Diseases2
Neuromuscular Diseases2
Autistic Disorder1
Genetic Diseases, X-Linked1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.